NUTRIFLEX LIPID PERI

Indications

• Fluid and electrolyte imbalances
• Hypoglycemia
• Nutritional supplementation
• Diabetic emergencies

Dosage

Children: Refer to the BNF for Children for appropriate paediatric dosing guidelines.

Adults: The dosage varies based on the clinical condition and specific formulation used. For intravenous administration, consult product literature for precise dosing.

Mechanism of action

Glucose supplies energy to tissues by undergoing glycolysis, which begins with its phosphorylation by hexokinase to form glucose 6-phosphate. This activates glucose for breakdown, ultimately generating ATP and NADH. The aerobic metabolism of glucose can yield up to 36 ATP molecules. Glucose also serves as a precursor for other biomolecules and regulates various physiological processes including gene transcription and hormone secretion.

Pharmacodynamics

Glucose is an obligatory energy source for cellular activities and plays a significant role in metabolic signaling. It is oxidized to yield energy through glycolysis, the citric acid cycle, and oxidative phosphorylation. Glucose can be converted into fat for energy storage and is stored as glycogen in the liver and muscles. Its administration increases blood glucose levels and stimulates insulin secretion, particularly through oral routes that activate gut incretin hormones.

Pharmacokinetics

Glucose is rapidly absorbed from the gastrointestinal tract or directly into the bloodstream when administered intravenously. It is distributed widely throughout the body and metabolized primarily in tissues requiring energy. The body maintains glucose homeostasis through regulatory mechanisms involving insulin and glucagon. Excess glucose can be stored as glycogen or converted to triglycerides for long-term energy storage.

Adverse effects

• Hyperglycemia
• Increased osmolarity
• Fluid overload
• Electrolyte imbalances

Interactions

• Insulin - may require dose adjustments

Precautions

• Use with caution in patients with diabetes mellitus
• Monitor blood glucose levels in patients receiving parenteral glucose
• Adjust dosage in renal impairment

Pregnancy

Glucose is generally considered safe in pregnancy; however, monitoring is advised, especially in diabetic patients.

Breast-feeding

Glucose is considered safe during breastfeeding, as it is a natural sugar found in breast milk.

Storage

Store at room temperature, away from light. Avoid freezing.

Formulations

• Glucose 5% solution for infusion
• Glucose 10% solution for infusion
• Glucose 0.9% solution for injection
• Glucose sodium chloride combination solutions

Indications

• Gastroesophageal reflux disease (GERD)
• Peptic ulcers
• Dyspepsia
• Acid-base balance disorders

Dosage

Children: Refer to specific acid formulations and guidelines for dosing. General dosing depends on the acid and its clinical use.

Adults: Refer to specific acid formulations and guidelines for dosing. General dosing depends on the acid and its clinical use.

Mechanism of action

Acids exert their effects primarily by dissociating into protons and anions in solution, thereby lowering the pH of the surrounding environment. This proton donation can influence various physiological processes, including enzyme activity, ion transport, and cellular signaling pathways. For example, hydrochloric acid in the stomach aids in digestion and the absorption of certain nutrients.

Pharmacodynamics

The pharmacodynamic effects of acids are largely dependent on their concentration and the specific type of acid involved. Weak acids may dissociate partially, leading to a less pronounced effect, while strong acids fully dissociate, leading to significant changes in pH and potential tissue irritation. Acids can also interact with various receptors and enzymes, influencing metabolic pathways and physiological responses.

Pharmacokinetics

The pharmacokinetics of acids vary widely depending on their chemical structure. Strong acids, such as hydrochloric acid, do not significantly enter systemic circulation due to their rapid dissociation in aqueous environments. Weak acids may be absorbed through the gastrointestinal tract, where their absorption is influenced by pH, solubility, and the presence of food. Metabolism and excretion pathways also vary, with some acids being metabolized to bicarbonate or other metabolites before excretion, primarily via the kidneys.

Adverse effects

• Gastrointestinal irritation
• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Electrolyte imbalance

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of gastrointestinal bleeding
• Consider potential interactions with other medications that may affect gastrointestinal motility or pH levels

Pregnancy

The safety of various acids during pregnancy may vary; consult specific guidelines for each acid. Generally, use should be limited to essential cases.

Breast-feeding

Caution is advised when using acids during breastfeeding; consult specific guidelines for each acid.

Storage

Store in a cool, dry place away from direct sunlight. Keep tightly closed and out of reach of children.

Indications

• Asthma
• Chronic obstructive pulmonary disease (COPD)
• Bronchospasm associated with respiratory conditions

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Aminophylline works as a phosphodiesterase inhibitor, leading to an increase in intracellular cyclic AMP (cAMP). This action results in the relaxation of bronchial smooth muscle, bronchodilation, and reduced airway resistance. It may also exert anti-inflammatory effects by inhibiting the release of inflammatory mediators from mast cells.

Pharmacodynamics

The pharmacodynamics of aminophylline involve its ability to enhance respiratory function by decreasing airway resistance, improving mucociliary clearance, and increasing respiratory muscle strength. Its therapeutic effects typically begin within 30 minutes of administration, with a peak effect occurring within 2 hours.

Pharmacokinetics

Aminophylline is rapidly absorbed following intravenous administration, with a bioavailability of approximately 100%. Its volume of distribution is large, indicating extensive tissue binding. The drug is metabolized primarily in the liver via cytochrome P450 enzymes, with a half-life ranging from 3 to 10 hours depending on patient factors, including age, liver function, and concurrent medications.

Interactions

• aminoglycosides+agalsidasealfa: Severe (decreases effects)
• aminoglycosides+agalsidasebeta: Severe (decreases effects)
• betablockers,selective+aminophylline: Severe (increases risk of bronchospasm)
• aminophylline+phosphodiesterasetype-: Severe (increases exposure)
• stiripentol+aminophylline: Severe (increases exposure)
• deferasirox+aminophylline: Severe (increases exposure)
• aminophylline+roflumilast: Severe (increases exposure)
• aciclovir+aminophylline: Moderate (increases exposure)
• aminophylline+macrolides: Moderate (decreases exposure)
• aminophylline+erythromycin: Moderate (decreases exposure)

Indications

• Dehydration
• Hyponatremia
• Hypernatremia
• Hypokalemia
• Hyperkalemia
• Hypocalcemia
• Hypercalcemia
• Hypomagnesemia
• Hypermagnesemia
• Acid-base imbalances

Dosage

Children: Electrolyte dosing in children varies depending on the specific electrolyte and the child's condition. Refer to pa

Adults: Electrolyte dosing varies based on the specific electrolyte and the clinical situation. Refer to specific guidelines or consult with a healthcare professional for appropriate dosing.

Mechanism of action

Electrolytes exert their effects by dissociating into ions in solution, which then participate in various physiological processes. For instance, sodium and potassium ions are crucial for generating action potentials in neurons and muscle cells, while calcium ions are vital for muscle contraction and neurotransmitter release. The movement of these ions across cell membranes is regulated by transporters and channels, influencing cellular excitability and overall homeostasis.

Pharmacodynamics

Electrolytes function mainly through their roles in fluid balance and neuromuscular activity. Sodium is primarily involved in maintaining osmotic pressure and is vital for the conduction of electrical impulses in nerves and muscles. Potassium is critical for cardiac rhythm and muscle function. Calcium is essential for muscle contractions, neurotransmitter release, and blood coagulation. Magnesium serves as a cofactor for numerous enzymatic reactions and helps regulate calcium levels.

Pharmacokinetics

Electrolytes are absorbed in the gastrointestinal tract and distributed throughout the body fluids. Their levels are regulated by the kidneys, which filter excess electrolytes to maintain homeostasis. Electrolytes can be lost through sweat, urine, and feces, and their replacement may be necessary in cases of dehydration, diarrhea, or other conditions causing imbalances. The half-lives of various electrolytes can vary, but they are typically rapidly equilibrated within the body's compartments.

Contra-indications

• Severe renal impairment
• Hyperkalemia
• Hypercalcemia
• Hypermagnesemia
• Severe dehydration

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal cramps
• Hypernatremia
• Hypokalemia
• Hyperkalemia
• Arrhythmias
• Muscle weakness

Interactions

• Diuretics (especially potassium-sparing diuretics may increase serum potassium levels)
• ACE inhibitors (may increase potassium levels)
• Lithium (sodium fluctuations can affect lithium levels)
• Digoxin (potassium levels can influence digoxin toxicity)

Precautions

• Monitor serum electrolyte levels regularly
• Use with caution in patients with renal impairment
• Monitor patients with cardiac conditions closely
• Assess fluid status and hydration before administration

Pregnancy

Electrolyte supplementation should be managed carefully during pregnancy, considering the specific needs of the mother and fetus.

Breast-feeding

Electrolytes are generally safe during breastfeeding, but specific needs should be evaluated.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

• Oral electrolyte solutions
• Intravenous electrolyte solutions
• Electrolyte tablets or powders

Indications

• Hyperlipidemia
• Dyslipidemia
• Cardiovascular disease prevention
• Metabolic syndrome
• Pancreatitis (in specific cases)

Dosage

Children: Dosage varies widely based on the specific lipid involved and the clinical condition being treated. Refer to BNF for Children for tailored dosing.

Adults: Dosage varies widely based on the specific lipid involved and the clinical condition being treated. Refer to specific guidelines or BNF for tailored dosing.

Mechanism of action

Lipids exert their effects through various mechanisms depending on their type. For instance, triglycerides primarily serve as energy sources, while phospholipids are key components of cell membranes, influencing membrane fluidity and permeability. Cholesterol, a type of sterol, contributes to membrane stability and fluidity, and it serves as a precursor for steroid hormones. Lipid signaling molecules, such as prostaglandins and leukotrienes, act through specific receptors to modulate inflammatory processes and other physiological responses.

Pharmacodynamics

The pharmacodynamics of lipids are predominantly related to their roles in cellular functions and metabolic pathways. They participate in energy metabolism through beta-oxidation in mitochondria, leading to ATP production. Additionally, lipids are involved in cell signaling pathways that regulate inflammation, immune responses, and hormonal activities, influencing various physiological processes.

Pharmacokinetics

Lipids are absorbed in the gastrointestinal tract after emulsification by bile salts and enzymatic hydrolysis by lipases. They are transported in the lymphatic system and enter the bloodstream as chylomicrons. Once in circulation, lipids are distributed throughout the body, stored in adipose tissue, or metabolized in the liver. The metabolic fate of lipids depends on their type and the body's energy needs, with pathways for storage, utilization, and conversion to other biomolecules.

Contra-indications

• Active liver disease
• Severe renal impairment
• Hypersensitivity to any component of the formulation

Adverse effects

• Gastrointestinal disturbances (nausea, vomiting, diarrhea)
• Increased liver enzymes
• Muscle pain or weakness (myopathy)
• Rhabdomyolysis (rare but serious)
• Pancreatitis
• Allergic reactions (rash, itching)

Interactions

• Increased risk of myopathy/rhabdomyolysis with statins and fibrates
• Cyclosporine may increase the risk of statin toxicity
• Warfarin may have altered anticoagulant effects
• Certain antibiotics and antifungals can increase statin concentrations

Precautions

• Monitor liver function tests before and during treatment
• Use caution in patients with a history of alcohol use disorder
• Consider regular monitoring of muscle symptoms in patients on high-dose statins
• Assess renal function, particularly in patients with existing renal impairment

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Statins are generally contraindicated.

Breast-feeding

Limited data, use caution as these agents may pass into breast milk.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Oral tablets (e.g., atorvastatin, simvastatin)
• Oral capsules (e.g., fenofibrate)
• Injectable formulations (e.g., omega-3 fatty acids)

Mechanism of action

Glucose supplies most of the energy to all tissues by generating energy molecules ATP and NADH during a series of metabolism reactions called glycolysis. Glycolysis can be divided into two main phases where the preparatory phase is initiated by the phosphorylation of glucose by hexokinase to form glucose 6-phosphate. The addition of the high-energy phosphate group activates glucose for the subsequent breakdown in later steps of glycolysis and is the rate-limiting step. Products end up as substrates for following reactions, to ultimately convert C6 glucose molecule into two C3 sugar molecules. These products enter the energy-releasing phase where the total of 4ATP and 2NADH molecules are generated per one glucose molecule. The total aerobic metabolism of glucose can produce up to 36 ATP molecules. These energy-producing reactions of glucose are limited to D-glucose as L-glucose cannot be phosphorylated by hexokinase. Glucose can act as precursors to generate other biomolecules such as vitamin C. It plays a role as a signaling molecule to control glucose and energy homeostasis. Glucose can regulate gene transcription, enzyme activity, hormone secretion, and the activity of glucoregulatory neurons. The types, number, and kinetics of glucose transporters expressed depends on the tissues and fine-tunes glucose uptake, metabolism, and signal generation to preserve cellular and whole body metabolic integrity. Vascular calcification is a hallmark of type 2 diabetes. Glucose stimulates calcification in culture of vascular smooth muscle cells (VSMCs) but the underlying mechanisms remain obscure. We observed that high glucose levels stimulated mouse and human VSMC trans-differentiation into chondrocytes, with increased levels of Sox9, type II collagen, glycosaminoglycan and Runx2 expression, and increased alkaline phosphatase activity and mineralization. These effects were associated with increased expression of IL-1beta, which stimulated alkaline phosphatase and calcification, suggesting that glucose induces chondrocyte differentiation of VSMCs, possibly through IL-1beta activation.

Pharmacodynamics

Blood glucose is an obligatory energy source for humans involved in various cellular activities, and it also acts as a signaling molecule for diverse glucose-sensing molecules and proteins. Glucose undergoes oxidation into carbon dioxide, water, and yields energy molecules in the process of glycolysis and subsequent citric cycle and oxidative phosphorylation. Glucose is readily converted into fat in the body which can be used as a source of energy as required. Under a similar conversion into storage of energy, glucose is stored in the liver and muscles as glycogen. Glucose stores are mobilized in a regulated manner, depending on the tissues' metabolic demands. Oral glucose tablets or injections serve to increase the supply of glucose and oral glucose administration is more effective in stimulating insulin secretion because it stimulates the incretin hormones from the gut, which promotes insulin secretion.